CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Jonathan Poole, Chief Financial Officer, will present a company overview at the upcoming UBS Global Healthcare Conference. The presentation is scheduled for Wednesday, May 20, 2015 at 11:00 a.m. EDT in New York, NY.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
